DiagnaMed Holdings Corp., a Canadian technology innovator specializing in advanced H₂ extraction technologies, announced its recent strategic acquisition in Ontario, serving as a critical proof of concept for the company's proprietary H₂ extraction technology, directly aligning with its commitment to clean H₂ energy solutions.

This acquisition strategically positions DiagnaMed to validate and demonstrate its H₂ extraction technology in practical, real-world applications. Additionally, this initiative complements the goals of the Ontario H₂ Innovation Fund, which recently announced a $30-MM investment to support projects that integrate low-carbon H₂ across various sectors, further reinforcing DiagnaMed's position as a leader in sustainable H₂ development.

"This strategic acquisition represents a pivotal step in validating and showcasing our proprietary H₂ extraction technology," stated Fabio Chianelli, President and CEO of DiagnaMed. "Leveraging Ontario’s supportive innovation ecosystem and aligning with initiatives such as the Ontario H₂ Innovation Fund, DiagnaMed is positioned to significantly advance sustainable H₂ development and contribute meaningfully to the cleantech life sciences sector."